| 2026-08-11 | Press release | IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test |
| 2026-08-04 | Deck | Earnings snapshot PDF · Q2 2026 |
| 2026-08-04 | Press release | IDEXX Laboratories Announces Second Quarter Results · 2026 |
| 2026-08-04 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-04 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-28 | Press release | IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals |
| 2026-07-01 | Press release | IDEXX Laboratories to Release 2026 Second Quarter Financial Results |
| 2026-05-26 | Press release | IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection |
| 2026-05-19 | Press release | IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles |
| 2026-05-15 | 8-K | Form 8-K, Item 5.03 |
| 2026-05-14 | Press release | IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day |
| 2026-05-05 | Press release | Earnings release Q1 2026 PDF |
| 2026-05-05 | Deck | Earnings presentation · Q1 2026 · May 2026 |
| 2026-05-05 | Press release | Press release · Q1 2026 · May 2026 |
| 2026-05-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-05 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-08 | Press release | IDEXX Laboratories to Release 2026 First Quarter Financial Results |
| 2026-03-27 | Proxy | Definitive proxy statement |
| 2026-03-26 | 8-K | Form 8-K, Item 5.02 |
| 2026-03-02 | Deck | Raymond James Institutional Investors Conference Presentation · Q1 2026 |
| 2026-02-20 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-13 | 8-K | Form 8-K, Item 5.02 |
| 2026-02-12 | Press release | IDEXX Laboratories to Present at Two Institutional Investor Conferences |
| 2026-02-03 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-02 | Press release | IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results |
| 2026-02-02 | Deck | Earnings snapshot · Q4 2025 |
| 2026-02-02 | 8-K | Form 8-K, Item 2.02 results |
| 2026-01-15 | Press release | Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus |
| 2026-01-13 | 8-K | Form 8-K, Item 5.02 |
| 2026-01-09 | Press release | IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results |
| 2025-11-13 | 8-K | Form 8-K, Item 1.01 |
| 2025-11-03 | Press release | IDEXX Laboratories Announces Third Quarter Results · 2025 |
| 2025-11-03 | Deck | Earnings snapshot · Q3 2025 |
| 2025-11-03 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-03 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-08 | Press release | IDEXX Laboratories to Release 2025 Third Quarter Financial Results |
| 2025-10-07 | 8-K | Form 8-K, Item 5.02 |
| 2025-08-14 | Deck | IDEXX Investor Day presentation |
| 2025-08-14 | Transcript | FY25 earnings call transcript |
| 2025-08-04 | Press release | IDEXX Laboratories Announces Second Quarter Results · 2025 |